PURPOSE OF REVIEW: The aim is to compare and contrast psychological treatments for amphetamine and cocaine dependence. RECENT FINDINGS: Stimulant dependence, in the form of cocaine or amphetamine/methamphetamine dependence, is prevalent worldwide, and their ratio may vary across different countries and regions of countries. The treatment of stimulant disorders has greatly advanced in recent years, and scientific evaluation of behavioral therapies, using randomized clinical trials designs and a stage-wise approach, have demonstrated the safety and efficacy of interventions. Psychological interventions such as cognitive behavioral therapy and contingency management for cocaine and methamphetamines use disorders are well tolerated and moderately effective in achieving drug abstinence. There is evidence that contingency management interventions can help to improve retention in treatment and, in turn, other treatment outcomes. Although there are important differences in the neuropsychiatric and medical consequences of cocaine and amphetamine use disorders, there is currently no evidence for a differential treatment effect of any psychosocial treatment in the management of these disorders. SUMMARY: As there are no Food and Drug Administration-approved medications for the treatment of these disorders, psychological interventions form the basis of their treatment. More research is needed to address the specific psychosocial needs of cocaine and amphetamine-dependent individuals in order to improve their treatment outcomes.
PURPOSE OF REVIEW: The aim is to compare and contrast psychological treatments for amphetamine and cocaine dependence. RECENT FINDINGS: Stimulant dependence, in the form of cocaine or amphetamine/methamphetamine dependence, is prevalent worldwide, and their ratio may vary across different countries and regions of countries. The treatment of stimulant disorders has greatly advanced in recent years, and scientific evaluation of behavioral therapies, using randomized clinical trials designs and a stage-wise approach, have demonstrated the safety and efficacy of interventions. Psychological interventions such as cognitive behavioral therapy and contingency management for cocaine and methamphetamines use disorders are well tolerated and moderately effective in achieving drug abstinence. There is evidence that contingency management interventions can help to improve retention in treatment and, in turn, other treatment outcomes. Although there are important differences in the neuropsychiatric and medical consequences of cocaine and amphetamine use disorders, there is currently no evidence for a differential treatment effect of any psychosocial treatment in the management of these disorders. SUMMARY: As there are no Food and Drug Administration-approved medications for the treatment of these disorders, psychological interventions form the basis of their treatment. More research is needed to address the specific psychosocial needs of cocaine and amphetamine-dependent individuals in order to improve their treatment outcomes.
Authors: Nancy M Petry; Jessica M Peirce; Maxine L Stitzer; Jack Blaine; John M Roll; Allan Cohen; Jeanne Obert; Therese Killeen; Michael E Saladin; Mark Cowell; Kimberly C Kirby; Robert Sterling; Charlotte Royer-Malvestuto; John Hamilton; Robert E Booth; Marilyn Macdonald; Marc Liebert; Linda Rader; Raynetta Burns; Joan DiMaria; Marc Copersino; Patricia Quinn Stabile; Ken Kolodner; Rui Li Journal: Arch Gen Psychiatry Date: 2005-10
Authors: Deborah B Leiderman; Steve Shoptaw; Ann Montgomery; Daniel A Bloch; Ahmed Elkashef; Joseph LoCastro; Frank Vocci Journal: Addiction Date: 2005-03 Impact factor: 6.526
Authors: Steven Shoptaw; Cathy J Reback; James A Peck; Xiaowei Yang; Erin Rotheram-Fuller; Sherry Larkins; Rosemary C Veniegas; Thomas E Freese; Christopher Hucks-Ortiz Journal: Drug Alcohol Depend Date: 2004-11-28 Impact factor: 4.492
Authors: Ahmed Elkashef; Tyson H Holmes; Daniel A Bloch; Steve Shoptaw; Kyle Kampman; Malcolm S Reid; Eugene Somoza; Domenic Ciraulo; John Rotrosen; Deborah Leiderman; Ann Montgomery; Frank Vocci Journal: Addiction Date: 2005-03 Impact factor: 6.526
Authors: Richard A Rawson; Patricia Marinelli-Casey; M Douglas Anglin; Alice Dickow; Yvonne Frazier; Cheryl Gallagher; Gantt P Galloway; James Herrell; Alice Huber; Michael J McCann; Jeanne Obert; Susan Pennell; Chris Reiber; Denna Vandersloot; Joan Zweben Journal: Addiction Date: 2004-06 Impact factor: 6.526
Authors: Tracy L Greer; Kolette M Ring; Diane Warden; Bruce D Grannemann; Timothy S Church; Eugene Somoza; Steven N Blair; Jose Szapocznik; Mark Stoutenberg; Chad Rethorst; Robrina Walker; David W Morris; Andrzej S Kosinski; Tiffany Kyle; Bess Marcus; Becca Crowell; Neal Oden; Edward Nunes; Madhukar H Trivedi Journal: J Glob Drug Policy Pract Date: 2012
Authors: Matthew J Mimiaga; Sari L Reisner; Yves-Michel Fontaine; Sean E Bland; Maura A Driscoll; Deborah Isenberg; Kevin Cranston; Margie R Skeer; Kenneth H Mayer Journal: Drug Alcohol Depend Date: 2010-03-23 Impact factor: 4.492
Authors: Matthew J Mimiaga; Elizabeth F Closson; David W Pantalone; Steven A Safren; Jennifer A Mitty Journal: Psychol Health Med Date: 2018-09-13 Impact factor: 2.423
Authors: Matthew J Mimiaga; Sari L Reisner; David W Pantalone; Conall O'Cleirigh; Kenneth H Mayer; Steven A Safren Journal: AIDS Patient Care STDS Date: 2012-10-03 Impact factor: 5.078